binosto once weekly 70 mg effervescent tablets
clonmel healthcare ltd - alendronic acid - effervescent tablet - 70 milligram(s) - bisphosphonates; alendronic acid - drugs affecting bone structure and mineralisation, bisphosphonates - treatment of postmenopausal osteoporosis. binosto 70 mg reduces the risk of vertebral and hip fractures
trianal tablet
laboratoire riva inc. - butalbital; caffeine; acetylsalicylic acid - tablet - 50mg; 40mg; 330mg - butalbital 50mg; caffeine 40mg; acetylsalicylic acid 330mg - salicylates
sandoz lovastatin tablet
sandoz canada incorporated - lovastatin - tablet - 20mg - lovastatin 20mg - hmg-coa reductase inhibitors
sandoz lovastatin tablet
sandoz canada incorporated - lovastatin - tablet - 40mg - lovastatin 40mg - hmg-coa reductase inhibitors
apo-zidovudine-lamivudine-nevirapine tablet
apotex inc - nevirapine; zidovudine; lamivudine - tablet - 200mg; 300mg; 150mg - nevirapine 200mg; zidovudine 300mg; lamivudine 150mg - nonnucleoside reverse transcriptase inhibitors
ava-lovastatin tablet
avanstra inc - lovastatin - tablet - 20mg - lovastatin 20mg - hmg-coa reductase inhibitors
ava-lovastatin tablet
avanstra inc - lovastatin - tablet - 40mg - lovastatin 40mg - hmg-coa reductase inhibitors
apo-nevirapine tablet
apotex inc - nevirapine - tablet - 200mg - nevirapine 200mg - nonnucleoside reverse transcriptase inhibitors
apo-nevirapine xr tablet (extended-release)
apotex inc - nevirapine - tablet (extended-release) - 400mg - nevirapine 400mg - nonnucleoside reverse transcriptase inhibitors
nevirapine wockhardt 400 mg prolonged-release tablets
wockhardt uk limited - nevirapine anhydrous - prolonged-release tablet - 400 milligram(s) - non-nucleoside reverse transcriptase inhibitors; nevirapine